![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comparison of Relative Bioavailability of TIVICAY Neonatal Liquid Formulations to Pediatric Dispersible Tablets
|
|
|
1GlaxoSmithKline, Collegeville, PA, USA; 2GlaxoSmithKline, Stockley Park, UK; 3GlaxoSmithKline, Ware, Hertfordshire, UK; 4ViiV Healthcare, RTP, NC, USA; 5ViiV Healthcare, Nyon, Switzerland
Correspondence to Rajendra Singh: rajendra.8.singh@gsk.com
![1001201](../images/100120/100120-3/1001201.gif)
![1001202](../images/100120/100120-3/1001202.gif)
![1001203](../images/100120/100120-3/1001203.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|